PVI
FOLD

Pura Vida Investments’s Amicus Therapeutics FOLD Stock Holding History

Pura Vida Investments’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-101,300
Closed -$1M – 241
2021
Q1 		$1M Sell
101,300
-453,800
-82% -$7.02M 0.03% 190
2020
Q4 		$12.8M Buy
555,100
+255,100
+85% +$5.22M 0.47% 59
2020
Q3 		$4.24M Buy
+300,000
New +$4.37M 0.22% 91

Other funds holding FOLD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Pura Vida Investments's FOLD Position: Q2 2021 in Review

Pura Vida Investments sold out of Amicus Therapeutics (FOLD) in Q2 2021, closing a stake of 45,525 shares — an estimated $444K sold.

Pura Vida Investments first reported a position in FOLD in Q1 2018 and held it in 6 quarters. The position peaked at $2.23M in Q3 2020. 235 funds tracked by Wall St. Rank hold FOLD as of Q2 2021.

  • Pura Vida Investments reported no remaining Amicus Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Pura Vida Investments sold 45,525 Amicus Therapeutics shares in Q2 2021, an estimated $444K.
  • Pura Vida Investments first reported a position in Amicus Therapeutics in Q1 2018 and held it in 6 quarters.
  • Pura Vida Investments's Amicus Therapeutics position peaked at $2.23M in Q3 2020.
  • 235 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.